Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC Directories Mobile Apps Celebrity VCs VentureTrackr Archive About Us
 
VC-funded Company:


SiteOne Therapeutics
960 Technology Blvd., STE 224
Bozeman, MT 59718
Phone: 650-260-8921
http://www.site1therapeutics.com/

SiteOne Therapeutics, headquartered in Bozeman, Montana, was founded with technology invented at Stanford University that represents a potential revolutionary advancement in the treatment of acute and chronic pain. The company's therapeutic candidates are highly selective sodium ion channel 1.7 (NaV1.7) inhibitors based on naturally occurring small molecules. Given the critical role NaV1.7 plays in the generation and conduction of pain signals, combined with the urgent need for new, non-opioid pain therapies, SiteOne is focused on advancing its lead product for the treatment of moderate to severe pain. Additional opportunities with the company's technology include long-acting analgesics, PET imaging diagnostics for pain and other pain indications. SiteOne owns worldwide development and commercialization rights to its development programs through an exclusive license from Stanford University.

Key Contact
NameTitleE-Mail
Stan E. AbelCEOstan.abel@site1therapeutics.com


Funding Events
DateAmountTypeInvestors
07/15/15undisclosed Biobrit
Mission Bay Capital
Next Frontier Capital
Sears Capital Management
Z Investments
01/09/17$15,000,000Series B 2M Companies
Amgen Ventures
Biobrit
Mission Bay Capital
Next Frontier Capital
Sears Capital Management
Z Investments
 
Massinvestor/VC News Daily
617-620-4606


© 2017 Massinvestor, Inc.